Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.

Simons, J W; Mikhak, B; Chang, J F; DeMarzo, A M; Carducci, M A; Lim, M; Weber, C E; Baccala, A A; Goemann, M A; Clift, S M; Ando, D G; Levitsky, H I; Cohen, L K; Sanda, M G; Mulligan, R C; Partin, A W; Carter, H B; Piantadosi, S; Marshall, F F; Nelson, W G

Simons, J W; Mikhak, B; Chang, J F; DeMarzo, A M; Carducci, M A; Lim, M; Weber, C E; Baccala, A A; Goemann, M A; Clift, S M; Ando, D G; Levitsky, H I; Cohen, L K; Sanda, M G; Mulligan, R C; Partin, A W; Carter, H B; Piantadosi, S; Marshall, F F; Nelson, W G.

Affiliation

Simons JW; Johns Hopkins Oncology Center, Brady Urological Institute, and Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

Cancer Res ; 59(20): 5160-8, 1999 Oct 15.

Article in En | MEDLINE | ID: mdl-10537292

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Vaccines, Synthetic / Granulocyte-Macrophage Colony-Stimulating Factor / Cancer Vaccines / Antigens, Neoplasm Type of study: Etiology_studies Limits: Humans / Male / Middle aged Language: En Journal: Cancer Res Year: 1999 Document type: Article Affiliation country:

Search on Google

Add to My VHL

XML

PubMed Links